RxDoctor Payments Data

Christopher Ackerman

Acute Care · Lubbock, TXNPI 1790220028

Payments from drug & device makers

$550in general payments, 2019–2025

Across 27 payments — averaging $20.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Grifols USA, LLC$133
  • Abiomed$64
  • Verona Pharma, Inc.$54
  • Mylan Specialty L.p.$47
  • Johnson & Johnson$37
  • Takeda Pharmaceuticals U.S.A., Inc.$33
  • plus $182 from 9 others

What the payments were for

  • Food & beverage$550100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$550 in reported general payments places this provider in the 55th percentile of 2,323 acute care providers in Texas.

See all acute care providers in Texas

Medicare billing

Part B allowed, 2024
$4,805
Medicare patients
36
Services billed
44

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other acute care in Lubbock

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →